These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18401552)

  • 21. Bevacizumab for choroidal neovascularization related to inflammatory diseases.
    Kramer M; Axer-Siegel R; Jaouni T; Reich E; Hemo I; Priel E; Averbukh E; Ehrlich R; Chowers I; Weinberger D; Amer R
    Retina; 2010 Jun; 30(6):938-44. PubMed ID: 20168273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months.
    Arevalo JF; Adan A; Berrocal MH; Espinoza JV; Maia M; Wu L; Roca JA; Quiroz-Mercado H; Ruiz-Moreno JM; Serrano MA;
    Retina; 2011 Feb; 31(2):353-63. PubMed ID: 20890239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thirty-two month follow-up of successful treatment of choroidal neovascularization from angioid streaks with intravitreal bevacizumab.
    Kovach JL; Schwartz SG; Hickey M; Puliafito CA
    Ophthalmic Surg Lasers Imaging; 2009; 40(1):77-9. PubMed ID: 19205505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization.
    Mandal S; Garg S; Venkatesh P; Mithal C; Vohra R; Mehrotra A
    Arch Ophthalmol; 2007 Nov; 125(11):1487-92. PubMed ID: 17998509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy.
    Mandal S; Sinha S; Abbas Z; Venkatesh P
    Indian J Ophthalmol; 2011; 59(4):338-9. PubMed ID: 21666337
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.
    Chan WM; Lai TY; Liu DT; Lam DS
    Am J Ophthalmol; 2007 Jun; 143(6):977-983. PubMed ID: 17459318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Furino C; Boscia F; Recchimurzo N; Besozzi G; Cardascia N; Sborgia L; Niro A; Sborgia C
    Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis.
    Tran TH; Fardeau C; Terrada C; Ducos De Lahitte G; Bodaghi B; Lehoang P
    Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1685-92. PubMed ID: 18682970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM; Lai TY; Liu DT; Lam DS
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of choroidal neovascularization using intravitreal bevacizumab.
    Pedersen R; Soliman W; Lund-Andersen H; Larsen M
    Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of choroidal neovascular membrane in retinitis pigmentosa with intravitreal bevacizumab.
    Malik A; Sood S; Narang S
    Int Ophthalmol; 2010 Aug; 30(4):425-8. PubMed ID: 20049508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neovascularization from optic nerve head drusen.
    Knape RM; Zavaleta EM; Clark CL; Khuddus N; Peden MC
    J AAPOS; 2011 Feb; 15(1):87-90. PubMed ID: 21397813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.
    Teixeira A; Moraes N; Farah ME; Bonomo PP
    Acta Ophthalmol Scand; 2006 Dec; 84(6):835-6. PubMed ID: 17083556
    [No Abstract]   [Full Text] [Related]  

  • 34. Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis.
    Parodi MB; Iacono P; Kontadakis DS; Zucchiatti I; Cascavilla ML; Bandello F
    Arch Ophthalmol; 2010 Sep; 128(9):1100-3. PubMed ID: 20837791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MICROSTRUCTURAL EFFECTS OF INTRAVITREAL BEVACIZUMAB IN IDIOPATHIC CHOROIDAL NEOVASCULARISATION.
    Shah SN; Kang QY; Fan XJ; Shahbaz F
    J Ayub Med Coll Abbottabad; 2015; 27(2):259-63. PubMed ID: 26411092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal bevacizumab for uveitic choroidal neovascularization.
    Doctor PP; Bhat P; Sayed R; Foster CS
    Ocul Immunol Inflamm; 2009; 17(2):118-26. PubMed ID: 19412874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy.
    Lai TY; Chan WM; Liu DT; Luk FO; Lam DS
    Br J Ophthalmol; 2008 May; 92(5):661-6. PubMed ID: 18356265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macular functional changes evaluated with MP-1 microperimetry after intravitreal bevacizumab for subfoveal myopic choroidal neovascularization: one-year results.
    Scupola A; Tiberti AC; Sasso P; Savastano MC; Mastrocola A; Marangoni D; Minnella AM; Falsini B; Balestrazzi E
    Retina; 2010 May; 30(5):739-47. PubMed ID: 20038860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
    Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A
    Retina; 2006; 26(9):988-93. PubMed ID: 17151484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal bevacizumab for choroidal neovascularization secondary to laser photocoagulation for central serous chorioretinopathy.
    Pikkel J; Rumelt S
    Eur J Ophthalmol; 2012; 22(3):488-91. PubMed ID: 21928270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.